Tuesday, January 31, 2012

RemedyMD Announces Investigate Cell Therapy LIMS and ELN

RemedyMD Announces Investigate Cell Therapy, a Revolutionary Research Management System for Blood and Marrow Transplant Centers

Investigate Cell Therapy is the first and only research management system to integrate key translational research components, including LIMS, ELN, biospecimen tracking and a patient registry into one platform

SALT LAKE CITY, Jan. 31, 2012 /PRNewswire/ -- RemedyMD, the leading provider of Translational Research Informatics, will launch Investigate™ Cell Therapy at the American Society for Blood and Marrow Transplantation BMT Tandem Meetings Feb. 1Feb. 5 in San Diego, Calif. (Booth #604).

"Investigate Cell Therapy is designed to improve research efficiencies, facilitate pattern recognition and accelerate discoveries in BMT centers," said Hank Wu, Investigate product manager for RemedyMD.

Fully integrated with ComprehensiveBMT™, Investigate Cell Therapy is the world's only blood and marrow research management system capable of integrating next-generation sequencing, cross-disease registries, and long-term complications and outcomes to advance cell therapy research. Researchers benefit from:
  • Aggregation of disparate data types from bench to bedside data sources with an intelligent ontology that harmonizes biospecimen, registry and outcomes data
  • 360-degree perspective of phenotypic and genotypic data for subjects, patients, diseases
  • Configurability that keeps up with the pace of research, without waiting for software coding or database administration
  • Multisite, real-time research collaboration without the cost and complexity of infrastructure building and maintenance
  • A suite of reporting, analysis, and data visualization tools that enable drag-and-drop reporting by researchers, scientists, and clinicians without writing SQL
Investigate Cell Therapy leverages the same research platform implemented at the Blood Research Institute of the Blood Center of Wisconsin to integrate lab information management systems (LIMS), study design and tracking, patient registries, and data mining and visualization.

"Research is fundamentally an exercise in pattern recognition," said Gary Kennedy, Founder and CEO of RemedyMD. "Bringing the power of Investigate™ to bear on cell therapy research will provide blood and marrow researchers with the technology they need to recognize new patterns and increase the speed of discovery."

RemedyMD will demonstrate Investigate Cell Therapy at BOOTH #604 at the 2012 Tandem Meetings in San Diego, Calif. beginning Feb. 1Feb. 5.

This product is for research use only and is not intended for clinical or cell processing purposes.
About RemedyMD, Inc.

RemedyMD is the leading provider of registries and registry-based products for Life Science Research. RemedyMD's disease registry software is cutting-edge research management software which enables researchers, clinicians and scientists to collect, aggregate, harmonize, and analyze data from widely disparate sources and then use Mosaic™ Platform tools and applications to identify patterns that result in accelerated discoveries and better clinical data management. For more information visit: www.RemedyMD.com.

Media Contacts
Kristofer Beldin, RemedyMD, (801) 870-9407 (cell), kris.beldin@remedymd.com

Sunday, January 22, 2012

Global LIMS Market Predicted to Reach $1.4 Billion by 2015

Global Laboratory Information Management Systems Market to Reach US$1.4 Billion by 2015, According to New Report by Global Industry Analysts, Inc.

GIA announces the release of a comprehensive global outlook on the Laboratory Information Management Systems (LIMS) Industry. Growth in the global LIMS market would be driven by the increasing adoption of LIMS solutions among research organizations in emerging markets. In addition, technological advancements and the growing popularity of SaaS LIMS are expected to enhance adoption. 

San Jose, California (PRWEB) January 19, 2012

Follow us on LinkedIn – Laboratory Information Management Systems (LIMS), a part of Information Management Systems, facilitates management of samples, instruments and users in a laboratory set-up through the use of computer hardware and software. China and India offer potential growth opportunities for vendors operating in the global Laboratory Information Management Systems (LIMS) market, largely due to the rapid strides made by the two nations in the technological sphere. Growth opportunities for LIMS market are also emerging from Eastern Europe driven by increased activity in pharmaceutical, biotech, and environmental markets.

With several companies expanding their operations in Southeast Asia and Eastern Europe, all businesses, irrespective of scale of operation, would require automated systems to create audit trails, track samples, provide detailed analyses, monitor features, and report from a remote location. Strong, and robust growth patterns in manufacturing industries across developing countries offer a lucrative business case for LIMS, since higher manufacturing activity translates into greater need for manufacturing quality control functions to meet the slated regulatory requirements. Additionally, increased investments in biotechnology and drug development in developing countries, and tougher regulatory requirements are expected to offer lucrative business opportunities for LIMS, as traceability of data gains importance under such a scenario that prioritizes compliance to regulatory norms.

Traditionally, LIMS systems were procured on outright purchase basis, which proved to be time consuming and involved high level of expenditure. The LIMS market is steadily warming up to the Internet based-Software as a Service (SaaS) model, wherein software applications hosted by service providers are licensed/rented to end-users for use over the Internet. Unlike other commercial LIMS applications, SaaS LIMS is hosted on service provider’s server rather than at the end-users lab, and can be accessed by end-users through the Internet. The supply on demand model leverages the benefits offered by service-oriented architecture, Web 2.0 technologies and cloud computing to offer efficient and reliable solutions featuring advanced capabilities, on-demand. SaaS LIMS offers multi-tenant feature, which allows usage of single application and database for managing data for various customers, while sorting each customer’s data separately. If deployed efficiently, SaaS LIMS model offers confidentiality, security and excellent return on investment, all of which are critical requirements in a laboratory set-up.

Though LIMS offers numerous advantages, deployment and implementation continues to be marred by several drawbacks and issues such as high upfront costs for in-house custom systems/solutions, longer implementation time for commercial LIMS solution, functional glitches in fulfilling integrative needs of global companies with dispersed laboratory operations, and competitive threat posed by alternative enterprise-wide operational management systems.

Global market for LIMS is highly competitive and is home to several leading players including Thermo Fisher Scientific, Labware, Labvantage, and Abbott/STARLIMS, among others. Several factors come into play during the vendor selection process such as vendor brand equity, reliability of solutions offered, and the degree of responsiveness to the client in the form of providing proactive technical and customer support services. As a result, players are required to keep updating their core competencies to fend off potential competition. Vendor visibility is crucial, especially in an environment marked by rapid, large-scale adoption of LIMS in a laboratory setting, and spiraling competition.

The research report titled “Laboratory Information Management Systems (LIMS): A Global Outlook” announced by Global Industry Analysts, Inc., provides a collection of statistical anecdotes, market briefs, and concise summaries of research findings. The report offers an aerial view of the industry, identifies major short to medium term market challenges, and growth drivers. Market discussions in the report are punctuated with fact-rich market data tables. Regional markets elaborated upon include United States, Europe, and India. Also included is an indexed, easy-to-refer, fact-finder directory listing the addresses, and contact details of companies worldwide.

For more details about this comprehensive industry report, please visit –
http://www.strategyr.com/Laboratory_Information_Management_Systems_Industry_Market_Report.asp

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

FDA to Implement Abbott's STARLIMS

Date: January 18, 2012
Abbott Park (NYSE: ABT) — Abbott announced today that the U.S. Food and Drug Administration (FDA) will begin implementing Abbott’s STARLIMS® software-based laboratory information management system.

STARLIMS LIMS software will be used to manage complex processes and the analysis of the vast amounts of information generated by FDA laboratories.

As part of a master agreement with Dovèl Technologies, a company that provides high-end software applications to government organizations, the FDA’s Office of Regulatory Affairs (ORA) will begin deploying LIMS solutions from STARLIMS, designed to enhance testing of food and drug chemistries, devices, forensics material and microbiology samples. The ORA operates mainly five types of laboratories in 14 separate locations. The LIMS solution will provide the needed capability to manage the analytical workflow operations in ORA labs for approximately 825 users supporting sample accountability, data analysis, document control, report generation, and other lab operation functions.

 “We’re looking forward to working on this important initiative,” said Isaac Friedman, head of Abbott’s STARLIMS business. “STARLIMS has a successful track record in implementing web-based LIMS for life sciences organizations, public health laboratories and a number of federal agencies.”
About STARLIMS

Based in Hollywood, Fla., Abbott’s STARLIMS business (http://www.starlims.com) is a leading provider of laboratory information management systems, with more than 20 years of LIMS experience.  STARLIMS products help improve the reliability of laboratory sampling processes, support compliance with domestic and international regulations and industry standards, and provide comprehensive reporting, monitoring and analysis capabilities. STARLIMS software is used for quality assurance and control, testing and monitoring, and research and development in government, manufacturing and life sciences organizations. With 12 development and support centers across the globe, STARLIMS serves customers in more than 40 countries.
About Abbott

Abbott (NYSE: ABT) is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs nearly 90,000 people and markets its products in more than 130 countries.